Inventor · disambiguated record
Gurvinder Singh Rekhi
Also filed as: REKHI GURVINDER · REKHI GURVINDER S · REKHI GURVINDER SINGH
12 granted patents·21 pending applications·270 citations·filing 2002–2019
90Inventor score
Files withRECRO GAINESVILLE LLC8ELAN CORP PLC7ELAN PHARMA INT LTD6REKHI GURVINDER SINGH3ALKERMES PHARMA IRELAND LTD2
Top patents by PatentIndex Score
33 records- 0197US6902742B2Multiparticulate modified release compositionELAN CORP PLC·Filed 2002·Granted Jun 7, 2005·236 cites·31 claims
- 0292US9132096B1Abuse resistant pharmaceutical compositionsREKHI GURVINDER SINGH·Filed 2014·Granted Sep 15, 2015·11 cites·15 claims
- 0387US8119163B2Nanoparticulate and controlled release compositions comprising cefditorenDEVANE JOHN G·Filed 2007·Granted Feb 21, 2012·15 cites·22 claims
- 0483US10092559B2Abuse resistant pharmaceutical compositionsRECRO GAINESVILLE LLC·Filed 2017·Granted Oct 9, 2018·1 cites·6 claims
- 0582US8992973B2Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochlorideREKHI GURVINDER SINGH·Filed 2012·Granted Mar 31, 2015·5 cites·18 claims
- 0677US9486451B2Abuse resistant pharmaceutical compositionsRECRO GAINESVILLE LLC·Filed 2015·Granted Nov 8, 2016·1 cites·5 claims
- 0774US9713611B2Abuse resistant pharmaceutical compositionsRECRO GAINESVILLE LLC·Filed 2016·Granted Jul 25, 2017·1 cites·25 claims
- 0867US2014248341A1Alcohol resistant enteric pharmaceutical compositionsALKERMES PHARMA IRELAND LTD·Filed 2014·Application pending·0 cites
- 0965US10960000B2Abuse resistant pharmaceutical compositionsRECRO GAINESVILLE LLC·Filed 2018·Granted Mar 30, 2021·0 cites·10 claims
- 1065US2019380969A1Controlled Release Compositions Comprising A Combination Of Isosorbide Dinitrate And Hydralazine HydrochlorideRECRO GAINESVILLE LLC·Filed 2019·Application pending·0 cites
- 1163US9452163B2Abuse resistant pharmaceutical compositionsRECRO GAINESVILLE LLC·Filed 2015·Granted Sep 27, 2016·0 cites·6 claims
- 1262US2018085315A1Alcohol resistant enteric pharmaceutical compositionsALKERMES PHARMA IRELAND LTD·Filed 2017·Application pending·0 cites
- 1362US2011008435A1Nanoparticulate and Controlled Release Compositions Comprising Aryl-Heterocyclic CompoundsELAN CORP PLC·Filed 2007·Application pending·0 cites
- 1461US10213389B2Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochlorideRECRO GAINESVILLE LLC·Filed 2016·Granted Feb 26, 2019·0 cites·6 claims
- 1561US2006240105A1Multiparticulate modified release compositionELAN CORP PLC·Filed 2006·Application pending·0 cites
- 1659US9463166B2Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochlorideRECRO GAINESVILLE LLC·Filed 2016·Granted Oct 11, 2016·0 cites·20 claims
- 1758US2004197405A1Multiparticulate modified release compositionELAN CORP PLC·Filed 2004·Application pending·0 cites
- 1858US2007098796A1Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochrlorideREKHI GURVINDER S·Filed 2005·Application pending·0 cites
- 1958US2011223244A1Alcohol resistant enteric pharmaceutical compositionsELAN PHARMA INT LTD·Filed 2011·Application pending·0 cites
- 2056US2012100209A1Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochlorideREKHI GURVINDER SINGH·Filed 2011·Application pending·0 cites
- 2156US2008113025A1Compositions comprising nanoparticulate naproxen and controlled release hydrocodoneELAN PHARMA INT LTD·Filed 2007·Application pending·0 cites
- 2256US2008102121A1Compositions comprising nanoparticulate meloxicam and controlled release hydrocodoneELAN PHARMA INT LTD·Filed 2007·Application pending·0 cites
- 2354US2010247636A1Nanoparticulate and controlled release compositions comprising nilvadipineELAN CORP PLC·Filed 2006·Application pending·0 cites
- 2454US2008118556A1Modified Release of Compositions Containing a Combination of Carbidopa, Levodopa and EntacaponeELAN CORP PLC·Filed 2006·Application pending·0 cites
- 2554US2007160675A1Nanoparticulate and controlled release compositions comprising a cephalosporinELAN CORP PLC·Filed 2006·Application pending·0 cites
- 2653US2017000783A1Multiparticulate Modified Release CompositionRECRO TECH LLC·Filed 2016·Application pending·0 cites
- 2752US2009297596A1Nanoparticulate and Controlled Release Compositions Comprising a Platelet Aggregation InhibitorELAN PHARMA INT LTD·Filed 2006·Application pending·0 cites
- 2851US2007098791A1Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochlorideREKHI GURVINDER S·Filed 2006·Application pending·0 cites
- 2951US2009297597A1Modified Release Ticlopidine CompositionsLIVERSIDGE GARY·Filed 2006·Application pending·0 cites
- 3050US9308177B2Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochlorideRECRO TECHNOLOGY LLC·Filed 2015·Granted Apr 12, 2016·0 cites·21 claims
- 3142US2011064803A1Nanoparticulate and controlled release compositions comprising vitamin k2ELAN PHARMA INT LTD·Filed 2006·Application pending·0 cites
- 3242US2009269400A1Nanoparticulate and Controlled Release Compositions Comprising a CephalosporinELAN PHARMA INT LTD·Filed 2006·Application pending·0 cites
- 3341US2010136106A1Modified Release Famciclovir CompositionsLIVERSIDGE GARY·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gurvinder Singh Rekhi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →